Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Depreciation and Depletion: 2009-2024

Historic Depreciation and Depletion for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $71.6 million.

  • UNITED THERAPEUTICS's Depreciation and Depletion rose 14.36% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.4 million, marking a year-over-year change of. This contributed to the annual value of $71.6 million for FY2024, which is 35.35% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Depreciation and Depletion of $71.6 million as of FY2024, which was up 35.35% from $52.9 million recorded in FY2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Depreciation and Depletion peaked at $71.6 million during FY2024, and registered a low of $49.7 million during FY2020.
  • For the 3-year period, UNITED THERAPEUTICS's Depreciation and Depletion averaged around $58.6 million, with its median value being $52.9 million (2023).
  • Data for UNITED THERAPEUTICS's Depreciation and Depletion shows a peak YoY spiked of 35.35% (in 2024) over the last 5 years.
  • UNITED THERAPEUTICS's Depreciation and Depletion (Yearly) stood at $49.7 million in 2020, then climbed by 0.20% to $49.8 million in 2021, then rose by 2.81% to $51.2 million in 2022, then grew by 3.32% to $52.9 million in 2023, then spiked by 35.35% to $71.6 million in 2024.